Atlas Trials

Tofacitinib for Inflammatory Eye Disease

Clinical trial NCT03580343 · UNKNOWN

Trial details

NCT number
NCT03580343
Sponsor
Washington University School of Medicine
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
UveitisScleritis
Start date
2019-04-04
Primary completion
2019-12-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.